Details of the Drug Reposition

General Information of This Drug (ID: DMCAUKW)

Drug Name
EMB-01   DMCAUKW
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neoplasm DISZKGEW 2A00-2F9Z Phase 1/2 [1]
Non-small-cell lung cancer DISI0V1B 2C25 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03797391) A Dose Escalation Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors. U.S. National Institutes of Health.